UiPath Surges 29% From a 52-Week Low as Short Sellers Feel Pain
UiPath surged 29% in a single session from a 52-week low driven by Anthropic competition fears, with 28.1% of float sold short raising the question of whether this is a genuine re-rating or a mechanic
UiPath Surges 29% From a 52-Week Low as Short Sellers Feel Pain
NEW YORK, August 7 —
UiPath, Inc. (PATH) jumped 29% in a single session after sliding to a 52-week low, with 28.1% of float sold short entering the day.
- PATH surged 29% in a single session from a 52-week low; shares at $14.79
- At 16.3x forward P/E with $512mn FCF and 17.3% YoY revenue growth, the selloff priced in competitive destruction well ahead of any confirming data
- September earnings: revenue growth rate and enterprise contract retention are the two numbers that decide whether this reversal holds
The 28% Short Float Is the Story Nobody's Writing
The stated cause of the selloff was Anthropic competition, specifically the fear that large language models would replace UiPath's robotic process automation platform before the company could adapt. That concern has real merit. But retail investors called the selloff irrational, and on this occasion, the mechanics backed them up. The market moved well ahead of any confirming data: UiPath reported $1.7bn in TTM revenue growing 17.3% YoY and generated $512mn in FCF. Those are not the numbers of a business in competitive freefall. With 28.1% of float sold short entering the session, the slide to a 52-week low set up the conditions for a squeeze. The single-session reversal, visible as a sharp vertical move in the chart above, is what ignition looks like. Whether conviction follows is a separate question entirely.
The Bear Case Survives the Squeeze
Short sellers are not wrong about the structural risk. Anthropic and its peers are building AI agents that execute multi-step workflows natively, which is precisely what UiPath sells to enterprise customers at scale. The company's $0.60 trailing EPS leaves limited buffer if growth decelerates faster than the 16.3x forward multiple assumes. September earnings are the first hard data point on whether enterprise contract renewals are actually holding. If large customers are quietly piloting agent-native alternatives, the signal appears first in bookings and net revenue retention, neither of which the selloff crowd bothered to measure. The squeeze compresses the short float. It does not resolve the competitive thesis.
Better Setup Than Yesterday, Not a Resolved Story
For growth investors, PATH is more interesting at a 52-week low than at a 52-week high, though "interesting" and "investable" are not the same word. The $512mn FCF provides a real floor argument: this company generates cash even if top-line growth softens. Value investors looking to stress-test that assumption against a range of growth scenarios can run the numbers through the DCF calculator before September arrives. If the revenue growth rate holds near 17%, the selloff was the overreaction retail called it on day one. If it slips below 10%, the Anthropic bears had a point and the squeeze gave them a cleaner exit than they deserved. The single number to watch: revenue growth rate in September.
Generate a full PATH breakdown, including fundamentals and report analysis, at our UiPath stock page.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
UiPath stock surged 29% despite hitting a 52-week low amid concerns over Anthropic competition, with retail investors calling the selloff irrational ahead of September earnings.